Business Context and Reporting Period
Company: Proteon Therapeutics, Inc. (Note: Input metadata lists "Protara," but the filing text identifies "Proteon Therapeutics, Inc.")
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2015
Reporting Period: Quarter ended September 30, 2015
Context: This filing announces the issuance of a press release detailing financial results for the quarter ended September 30, 2015. The press release is attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached press release (Exhibit 99.1), which is not included in the input text.
Available Data: None. The filing text does not provide a clear value for any financial metric.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only references the announcement of results for the quarter ended September 30, 2015.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on November 12, 2015, but does not summarize the content of that commentary.
Guidance and Outlook: Not provided in the text.
Risks and Contingencies: Not provided in the text.
Unusual Items: Not provided in the text.
Investor Verification Checklist
- Verify the specific financial results (revenue, net loss, cash position) by reviewing Exhibit 99.1 (Press Release dated November 12, 2015), as these numbers are not in the 8-K body.
- Confirm the company name is Proteon Therapeutics, Inc., noting the discrepancy with the "Protara" label in the request metadata.
- Check for any forward-looking statements or updated clinical trial milestones in the attached press release.
- Review the liquidity position and cash burn rate detailed in the full press release to assess runway.